We just received data on a new analyst forecast for $ERAS. Alec Stranahan from B of A Securities set a price target of 1.0 for ERAS.
To track analyst ratings and price targets for $ERAS, check out Quiver Quantitative's $ERAS forecast page.
$ERAS Price Targets
Multiple analysts have issued price targets for $ERAS recently. We have seen 5 analysts offer price targets for $ERAS in the last 6 months, with a median target of $3.0.
Here are some recent targets:
- Alec Stranahan from B of A Securities set a target price of $1.0 on 09/03/2025
- Jeffrey Hung from Morgan Stanley set a target price of $2.0 on 08/18/2025
- Andres Maldonado from HC Wainwright & Co. set a target price of $6.0 on 04/30/2025
- Laura Prendergast from Raymond James set a target price of $5.0 on 03/26/2025
- Chris Shibutani from Goldman Sachs set a target price of $3.0 on 03/21/2025
$ERAS Hedge Fund Activity
We have seen 84 institutional investors add shares of $ERAS stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SILVERARC CAPITAL MANAGEMENT, LLC removed 4,798,405 shares (-65.1%) from their portfolio in Q2 2025, for an estimated $6,093,974
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,039,997 shares (+17.6%) to their portfolio in Q2 2025, for an estimated $3,860,796
- PFM HEALTH SCIENCES, LP removed 2,417,335 shares (-69.3%) from their portfolio in Q2 2025, for an estimated $3,070,015
- SUVRETTA CAPITAL MANAGEMENT, LLC added 2,187,000 shares (+17.8%) to their portfolio in Q2 2025, for an estimated $2,777,490
- WOODLINE PARTNERS LP removed 2,073,043 shares (-50.0%) from their portfolio in Q2 2025, for an estimated $2,632,764
- LOGOS GLOBAL MANAGEMENT LP added 2,000,000 shares (+15.4%) to their portfolio in Q2 2025, for an estimated $2,540,000
- SOFINNOVA INVESTMENTS, INC. removed 1,877,085 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,383,897
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
